Neutrophil-to-lymphocyte ratio an inflammatory biomarker, and prognostic marker in heart failure, cardiovascular disease and chronic inflammatory diseases: New insights for a potential predictor of anti-cytokine therapy responsiveness

• Published in: Microvascular research Vol. 150; p. 104598
• Main Authors: García-Escobar, Artemio, Vera-Vera, Silvio, Tébar-Márquez, Daniel, Rivero-Santana, Borja, Jurado-Román, Alfonso, Jiménez-Valero, Santiago, Galeote, Guillermo, Cabrera, José-Ángel, Moreno, Raúl
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01.11.2023
• Subjects: Anti-cytokine therapy; Antiinflammatory therapy; Atherosclerotic cardiovascular disease; COVID-19; Heart failure; Immune response; Inflammation; Lymphocyte; Major adverse cardiovascular events; Neutrophil; Neutrophil-to-lymphocyte ratio; Heart failure; COVID-19; Immune response; Antiinflammatory therapy; Atherosclerotic cardiovascular disease; Major adverse cardiovascular events; Neutrophil-to-lymphocyte ratio; Inflammation; Neutrophil; Lymphocyte; Anti-cytokine therapy

In the 20th century, research focused on cholesterol and lipoproteins as the key mechanism in establishing atherosclerotic cardiovascular disease (ASCVD). Given that some studies demonstrated subclinical atherosclerosis in subjects without conventional cardiovascular risk factors, the elevated low-d...